Psagot Value Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
MIH
RJA
Psagot Value Holdings's PPH Position: Q3 2018 in Review
Psagot Value Holdings sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2018, closing a stake of 17,000 shares — an estimated $1M sold.
Psagot Value Holdings first reported a position in PPH in Q2 2013 and held it in 21 quarters. The position peaked at $2.2M in Q1 2015. 44 funds tracked by Wall St. Rank hold PPH as of Q3 2018.
- Psagot Value Holdings reported no remaining VanEck Pharmaceutical ETF position as of Q3 2018 after selling out during the quarter.
- Psagot Value Holdings sold 17,000 VanEck Pharmaceutical ETF shares in Q3 2018, an estimated $1M.
- Psagot Value Holdings first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 21 quarters.
- Psagot Value Holdings's VanEck Pharmaceutical ETF position peaked at $2.2M in Q1 2015.
- 44 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2018.
Based on Psagot Value Holdings's 13F filing for Q3 2018, filed 5 Nov 2018.